PressDecember 10, 2021 Mydecine Secures Financing and Provides Company Update on Clinical Trials, Drug Development and Technology Initiatives
PressDecember 9, 2021 MindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System
PressDecember 8, 2021 Algernon Pharmaceuticals Completes Manufacturing of DMT, Appoints UK Stroke Experts for Phase 2
PressDecember 7, 2021 Mycotopia and Ei.Ventures sign LOI to Explore Merger and Formation of PSLY.COM, a $360 Million Transaction, And Will Apply To List Shares On NASDAQ
PressDecember 6, 2021 Mydecine Files Full Patent Application Covering Multiple Families of Psilocin Analogs
PressDecember 2, 2021 Tryp Therapeutics Receives Confirmation from FDA to Proceed with Phase 2a Study in Fibromyalgia
PressDecember 2, 2021 Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note
PressDecember 1, 2021 MindMed and Liechti Lab publish first human data on the interacting effects of an SSRI and psilocybin
PressNovember 30, 2021 Clairvoyant Therapeutics Raises More Than $3 Million in Seed Financing, Adds Bench Strength to Senior Leadership Team
PressNovember 29, 2021 Albert Labs Receive Conditional Approval for CSE Listing & Appoint Chrystal Capital Partners to Advise on European Listing
PressNovember 29, 2021 Biomind Labs Announces Design of a Pharmaceutical Form for Psychedelic Drug Delivery Using 3D Printing
PressNovember 22, 2021 Field Trip Health Ltd. Reports Second Fiscal Quarter 2022 Financial Results and Provides Business Update
PressNovember 19, 2021 Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders
PressNovember 18, 2021 Filament Health Announces Co-Development and Exclusive Licensing Agreement with Entheotech Bioscience
PressNovember 18, 2021 Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods
PressNovember 16, 2021 MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights
PressNovember 15, 2021 atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate Update
PressNovember 12, 2021 MYND Executes LOI to Enter into a Clinical Research Collaboration with Revitalist
